LN-040

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLN-040
Drug Alias Nameautologous cell vaccine (LipoNova)LN-040
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipoNova AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipoNova AG
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A